We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Smart Contact Lenses Powered by Micrometres-Thin Tear-Based Battery Can Flag Diseases

By HospiMedica International staff writers
Posted on 25 Aug 2023

Advanced contact lenses, known as smart contact lenses, have the remarkable capability to display visible information on our corneas and facilitate access to augmented reality. More...

These lenses serve multiple purposes, including vision correction, health monitoring, and disease detection for individuals with chronic conditions like diabetes and glaucoma. In the future, they might even capture and transmit wearers' sensory experiences to cloud-based data storage. However, the realization of this potential depends on the development of a suitable and safe battery to power these lenses. Existing rechargeable batteries rely on metal-containing wires or induction coils, making them inappropriate for ocular use due to discomfort and associated risks.

Scientists from NTU Singapore (Singapore) have successfully created a flexible battery, as thin as a human cornea, which stores electricity when immersed in saline solution, thereby offering the potential to power smart contact lenses. The NTU-developed battery is built from biocompatible materials and is devoid of wires or toxic heavy metals found in lithium-ion batteries and wireless charging systems. It features a glucose-based coating that interacts with sodium and chloride ions in the surrounding saline solution. The water within the battery functions as the conduit for generating electricity. The battery can also harness power from human tears, which contain sodium and potassium ions in lower concentrations. Testing with a simulated tear solution indicated that the battery's lifespan could be extended by an hour for every twelve-hour wearing cycle. Moreover, it can be conventionally charged using an external power source.

The innovation was put to the test using a simulated human eye. Merely 0.5 millimeters thick, the battery draws power from basal tears, the continuous tears that form a thin film over our eyeballs. The battery's glucose oxidase coating reacts with the sodium and chloride ions in tears, generating current within the contact lenses for embedded devices to function. It was demonstrated that the battery produces a current of 45 microamperes and a maximum power of 201 microwatts, sufficient for powering smart contact lens. Lab tests revealed that the battery could be charged and discharged up to 200 times, while typical lithium-ion batteries endure around 300 to 500 charging cycles. The research team suggests that the battery should be immersed in a suitable solution rich in glucose, sodium, and potassium ions for at least eight hours during sleep to facilitate charging. The NTU team aims to further enhance the battery's electrical output and collaborate with contact lens manufacturers to implement this technology.

“Although wireless power transmission and supercapacitors supply high power, their integration presents a significant challenge due to the limited amount of space in the lens,” said co-first author Ms. Li Zongkang, a PhD student from NTU’s EEE. “By combining the battery and biofuel cell into a single component, the battery can charge itself without the need for additional space for wired or wireless components. Furthermore, the electrodes placed at the outer side of the contact lens ensures that the vision of the eye cannot be obstructed.”

Related Links:
NTU Singapore 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Tourniquet System
heidi– mein Tourniquet
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.